Atai Beckley Ownership | Who Owns Atai Beckley?
Atai Beckley Ownership Summary
Atai Beckley is owned by 2.14% institutional investors, 3.70% insiders, and 94.16% retail investors. Adage capital partners gp is the largest institutional shareholder, holding 2.76% of ATAI shares. ARK Genomic Revolution ETF is the top mutual fund, with 1.65% of its assets in Atai Beckley shares.
ATAI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Atai Beckley | 2.14% | 3.70% | 94.16% |
| Sector | Healthcare Stocks | 231.98% | 10.74% | -142.72% |
| Idea | Psychedelic Stocks List | 20.20% | 9.72% | 70.08% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Adage capital partners gp | 5.43M | 2.76% | $28.75M |
| Morgan stanley | 4.82M | 2.22% | $19.72M |
| Blackrock funding, inc. /de | 2.81M | 1.29% | $11.51M |
| Ally bridge group (ny) | 2.29M | 1.16% | $12.10M |
| T. rowe price investment management | 1.94M | 0.99% | $10.26M |
| Blackrock | 1.31M | 0.82% | $1.74M |
| Eagle health investments lp | 1.68M | 0.77% | $6.86M |
| Hrt financial lp | 1.47M | 0.68% | $6.01M |
| Millennium management | 981.56K | 0.61% | $1.31M |
| Pale fire capital se | 1.08M | 0.55% | $5.72M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ally bridge group (ny) | 2.29M | 7.37% | $12.10M |
| Brummer multi-strategy ab | 234.91K | 5.81% | $960.80K |
| Brown university | 718.50K | 2.06% | $2.94M |
| Eagle health investments lp | 1.68M | 1.51% | $6.86M |
| Pale fire capital se | 1.08M | 0.63% | $5.72M |
| Adar1 capital management | 913.24K | 0.45% | $4.83M |
| Stableford capital ii | 291.56K | 0.43% | $1.19M |
| Advisorshares investments | 548.60K | 0.37% | $2.24M |
| Catalio capital management, lp | 196.86K | 0.19% | $1.04M |
| Centerbook partners lp | 780.50K | 0.16% | $3.19M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 2.81M | 0.00% | 2.81M |
| Ally bridge group (ny) | 2.29M | 7.37% | 2.29M |
| T. rowe price investment management | 1.94M | 0.01% | 1.94M |
| Eagle health investments lp | 1.68M | 1.51% | 1.68M |
| Hrt financial lp | 1.47M | 0.02% | 1.07M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | - | - | -7.68M |
| Walleye capital | - | - | -2.26M |
| Ark investment management | - | - | -2.02M |
| Pale fire capital se | 1.08M | 0.63% | -1.56M |
| Davidson kempner capital management lp | - | - | -1.41M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ally bridge group (ny) | 2.29M | 7.37% | 2.29M | $12.10M |
| T. rowe price investment management | 1.94M | 0.01% | 1.94M | $10.26M |
| Eagle health investments lp | 1.68M | 1.51% | 1.68M | $6.86M |
| Adar1 capital management | 913.24K | 0.45% | 913.24K | $4.83M |
| Fred alger management | 488.86K | 0.01% | 488.86K | $2.59M |
Sold Out
| Holder | Change |
|---|---|
| Grey fox wealth advisors | -40.00 |
| Rothschild investment | -50.00 |
| Nelson, van denburg & campbell wealth management group | -57.00 |
| Org partners | -90.00 |
| Glen eagle advisors | -166.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 38 | -72.46% | 4,651,628 | -89.35% | 2 | 0.43% | 19 | -77.38% | 6 | -57.14% |
| Sep 30, 2025 | 46 | -50.00% | 4,177,343 | -82.19% | 2 | 1.20% | 29 | -25.64% | 2 | -90.91% |
| Jun 30, 2025 | 97 | 14.12% | 29,160,750 | 33.18% | 16 | 10.72% | 41 | 46.43% | 23 | 9.52% |
| Mar 31, 2025 | 85 | -6.59% | 21,905,949 | 50.78% | 12 | 15.19% | 28 | -33.33% | 21 | 61.54% |
| Dec 31, 2024 | 88 | 14.29% | 14,501,746 | 24.52% | 9 | 17.17% | 41 | 78.26% | 13 | -38.10% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Genomic Revolution ETF | 3.26M | 1.65% | - |
| ARK Genomic Revolution | 3.17M | 1.60% | 1.21M |
| iShares Biotechnology ETF | 2.01M | 1.02% | 1.15M |
| Candriam Eqs L Biotech C USD Cap | 1.72M | 0.87% | 190.54K |
| HBM Healthcare Investments AG Ord | 1.50M | 0.76% | 1.50M |
| Columbia Acorn Inst | 909.73K | 0.46% | - |
| Morgan Stanley Inception | 843.39K | 0.43% | 19.43K |
| Morgan Stanley Inst Inception I | 843.39K | 0.43% | -130.65K |
| Kieger Impact Healthcare A USD Acc | 644.10K | 0.38% | 205.80K |
| Horizons Psychedelic Stock ETF | 520.20K | 0.31% | -82.78K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 14, 2025 | Apeiron Investment Group Ltd. | - | Buy | $19.00M |
| Mar 21, 2025 | Kirpekar Sahil | Chief Business Officer | Sell | $65.56K |
| Mar 21, 2025 | Craig Kevin James | Chief Medical Officer | Sell | $15.61K |
| Mar 21, 2025 | Rao Srinivas | See Remarks | Sell | $101.81K |
| Mar 21, 2025 | Johnson Anne Nagengast | Chief Financial Officer | Sell | $45.29K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | 1 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | 2 | 5 |
| 2024 Q4 | - | - |
ATAI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools